1-167765627-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_003953.6(MPZL1):āc.136A>Gā(p.Ile46Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000236 in 1,612,980 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_003953.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MPZL1 | NM_003953.6 | c.136A>G | p.Ile46Val | missense_variant | 2/6 | ENST00000359523.7 | NP_003944.1 | |
MPZL1 | NM_024569.5 | c.136A>G | p.Ile46Val | missense_variant | 2/5 | NP_078845.3 | ||
MPZL1 | NM_001146191.2 | c.136A>G | p.Ile46Val | missense_variant | 2/3 | NP_001139663.1 | ||
MPZL1 | XM_047433610.1 | c.-237A>G | 5_prime_UTR_variant | 3/7 | XP_047289566.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MPZL1 | ENST00000359523.7 | c.136A>G | p.Ile46Val | missense_variant | 2/6 | 1 | NM_003953.6 | ENSP00000352513.2 |
Frequencies
GnomAD3 genomes AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000160 AC: 4AN: 249992Hom.: 0 AF XY: 0.0000148 AC XY: 2AN XY: 135166
GnomAD4 exome AF: 0.0000246 AC: 36AN: 1460804Hom.: 1 Cov.: 31 AF XY: 0.0000234 AC XY: 17AN XY: 726738
GnomAD4 genome AF: 0.0000131 AC: 2AN: 152176Hom.: 0 Cov.: 32 AF XY: 0.00 AC XY: 0AN XY: 74344
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Apr 25, 2022 | The c.136A>G (p.I46V) alteration is located in exon 2 (coding exon 2) of the MPZL1 gene. This alteration results from a A to G substitution at nucleotide position 136, causing the isoleucine (I) at amino acid position 46 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at